All Blogs

Nov 04, 2025

Introduction The introduction of medical drones, or unmanned aerial vehicles (UAVs) for healthcare, represents a paradigm shift in medical logistics, fundamentally changing how critical supplies and diagnostic samples are transported. Over the past decade, these platforms have rapidly transitioned from limited e...

Dec 25, 2024

In the rapidly evolving healthcare sector, technology plays a pivotal role in transforming patient care, improving operational efficiency, and enhancing overall healthcare delivery. One of the most impactful advancements is the integration of healthcare mobility solutions.  From mobile health (mHealth) apps...

May 29, 2026

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can affect multiple parts of the body. In 2025, it was estimated that around 512,000 individuals in the United States were living with SLE, as per DelveInsight analysis, with new treatments for SLE urgently needed as 40% of treated SLE patien...

Dec 20, 2024

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally, according to the World Health Organization (WHO). It affects approximately 251 million people worldwide. Smoking is the leading cause of COPD, responsible for around 70-90% of cases. However, exposure to air pollution, occupa...

Dec 19, 2024

Siemens Healthineers Acquired Novartis’s Advanced Accelerator Applications Molecular Imaging  On December 10, 2024, Siemens Healthineers completed the acquisition of Advanced Accelerator Applications Molecular Imaging from Novartis. This European manufacturing and distribution network specializes in diagnos...

Dec 18, 2024

Access to healthcare is a fundamental human right, yet millions of people around the world face significant barriers to receiving timely and effective medical attention. Whether due to geographic isolation, economic disparities, or a shortage of healthcare facilities, these barriers can lead to worsening health out...

Dec 17, 2024

Neurocrine Announces FDA Approval of CRENESSITY for Congenital Adrenal Hyperplasia Neurocrine Biosciences, Inc. announced that the FDA has approved CRENESSITY™ (crinecerfont) as an adjunctive treatment to glucocorticoid replacement for controlling androgens in adult and pediatric patients aged four years and old...

Dec 16, 2024

Merus had a standout start this month. Shortly after landing a long-anticipated commercialization partner for its zenocutuzumab, the drug has achieved FDA approval, becoming the first therapy to target cancers with a neuregulin 1 (NRG1) gene fusion. The FDA granted accelerated approval to the drug, now marketed ...

Dec 13, 2024

AstraZeneca has secured another approval for its cancer blockbuster IMFINZI (durvalumab), as the FDA has approved the PD-L1 inhibitor for patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following concurrent chemotherapy and radiation. This approval makes IMFINZI the ...

Dec 12, 2024

China's NMPA Approved Magbot Robotic Magnetic Navigation Ablation Catheter On December 9, 2024, Stereotaxis and Shanghai MicroPort EP Medtech Co., Ltd., announced that the Magbot™ Magnetic Navigation Ablation Catheter received regulatory approval from China’s National Medical Products Administration (NMPA). T...